XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities:    
Net loss $ (62,421) $ (69,580)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 417 513
Amortization of intangibles 9,011 9,011
Amortization of premium/discount on investments 0 (11)
Non-cash interest expense related to sale of future royalties 2,345 2,162
Non-cash royalty revenue related to sale of future royalties (329) (20)
Non-cash interest expense 246 229
Non-cash operating lease expense (557) (494)
Fair value step-up of inventory sold or written off 0 21,575
Write-down of inventory 5,344 5,075
Change in excess inventory purchase commitments (773) (8,945)
Stock-based compensation 4,536 5,992
Change in fair value of derivative liability (710) 80
Changes in operating assets and liabilities:    
Accounts receivable (13,707) (8,380)
Inventory (5,247) (19,193)
Prepaid expenses and other current assets 9,019 2,268
Other long-term assets 3,297 1,361
Accounts payable (7,358) (4,912)
Accrued expense 4,426 (4,877)
Operating lease liabilities 616 407
Deferred revenue 33,416 (3,007)
Other non-current liabilities (3,191) 0
Net cash used in operating activities (21,620) (70,746)
Investing activities:    
Purchase of equipment (114) (59)
Proceeds from the maturities of available for sale securities 0 20,000
Net cash (used in) provided by investing activities (114) 19,941
Financing activities:    
Proceeds from sale of future royalties, net 0 44,783
Proceeds from refund liabilities to customers 40,000 0
Proceeds from the issuance of common stock, net of issuance costs 7,178 29,327
Proceeds from the sale of stock under employee stock purchase plan 367 367
Proceeds from the exercise of stock options 0 0
Net cash provided by financing activities 47,545 74,477
Increase in cash, cash equivalents, and restricted cash 25,811 23,672
Cash, cash equivalents, and restricted cash at beginning of the period 151,839 231,132
Cash, cash equivalents, and restricted cash at end of the period 177,650 254,804
Non-cash financing activities    
Unpaid offering costs $ 0 $ 171